Literature DB >> 24711056

Lipid levels in dissociative disorders: effects of psychodynamic psychotherapy.

Cristian Damsa1, Coralie Lazignac, Nick Miller, Susanne Maris, Eric Adam, Kevin Rossignon.   

Abstract

Although there are several data suggesting a link between lower lipids levels and the risk of suicide, there are few data concerning lower lipids levels in patients with dissociative disorders (DD). This is the first longitudinal study investigating the evolution of the lipids levels during a specific 8 weeks of psychodynamic psychotherapy (PP) for patients with DD. 32 patients diagnosed with DD (SCID for DSMIVR) were assessed with Dissociative Experiences Scale (DES), Clinical Global Impression and Improvement Scale and their lipids levels (total cholesterol, triglycerides, high-density lipoprotein, low-density lipoprotein and very low density lipoprotein) were measured at inclusion and after 3 and 8 weeks of PP. 30 patients finished the study. There is a significant positive (p < 0.05) link between lower lipids levels (total cholesterol, LDL, triglycerids) and a higher level of dissociation (DES scores) at the beginning and at the end of the study. Interestingly, we found a significant (p = 0.018) positive link between the reduction of the dissociation (DES) and the increase of the triglycerides levels after 8 weeks of treatment. While lower lipids seems related to a higher level of dissociation before and after the treatment, an increasing triglycerides level was observed after 8 weeks of PP in patients with a better outcome. Further studies are needed with larger samples and control groups, in order to confirm these preliminary data. These findings could open the way for hypothesis about the role of lipids in the pathophysiology of DD and raise the question of the patients with DD receiving antilipidemiants agents.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24711056     DOI: 10.1007/s11126-014-9297-3

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  11 in total

1.  Low serum cholesterol and suicide.

Authors:  H Engelberg
Journal:  Lancet       Date:  1992-03-21       Impact factor: 79.321

2.  The Revised Helping Alliance Questionnaire (HAq-II) : Psychometric Properties.

Authors:  L Luborsky; J P Barber; L Siqueland; S Johnson; L M Najavits; A Frank; D Daley
Journal:  J Psychother Pract Res       Date:  1996

Review 3.  [Dissociative disorders: clinical, neurobiological and therapeutical approaches].

Authors:  C Damsa; C Lazignac; R Pirrotta; A Andreoli
Journal:  Rev Med Suisse       Date:  2006-02-08

4.  Sleep-related violence and low serum cholesterol: a preliminary study.

Authors:  Mehmed Yucel Agargun; M Ramazan Sekeroğlu; Hayrettin Kara; Omer Akil Ozer; Temel Tombul; Umit Kiran; Yavuz Selvi
Journal:  Psychiatry Clin Neurosci       Date:  2002-04       Impact factor: 5.188

5.  Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk.

Authors:  M Elizabeth Sublette; Joseph R Hibbeln; Hanga Galfalvy; Maria A Oquendo; J John Mann
Journal:  Am J Psychiatry       Date:  2006-06       Impact factor: 18.112

6.  Serum lipid levels in patients with dissociative disorder.

Authors:  Mehmet Yücel Agargun; Omer Akil Ozer; Hayrettin Kara; Ramazan Sekeroglu; Yavuz Selvi; Buket Eryonucu
Journal:  Am J Psychiatry       Date:  2004-11       Impact factor: 18.112

7.  Development, reliability, and validity of a dissociation scale.

Authors:  E M Bernstein; F W Putnam
Journal:  J Nerv Ment Dis       Date:  1986-12       Impact factor: 2.254

8.  Dissociative disorders and suicidality in psychiatric outpatients.

Authors:  Brad Foote; Yvette Smolin; Deborah I Neft; Deborah Lipschitz
Journal:  J Nerv Ment Dis       Date:  2008-01       Impact factor: 2.254

9.  Clinical application of low serum cholesterol as an indicator for suicide risk in major depression.

Authors:  Yong-Ku Kim; Aye-Mu Myint
Journal:  J Affect Disord       Date:  2004-08       Impact factor: 4.839

10.  Prevalence of dissociative disorders in psychiatric outpatients.

Authors:  Brad Foote; Yvette Smolin; Margaret Kaplan; Michael E Legatt; Deborah Lipschitz
Journal:  Am J Psychiatry       Date:  2006-04       Impact factor: 19.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.